Endothelial dysfunction is characterized by an impairment of pulmonary vessel dilation, particularly mediated by overexpression of endothelin 1 (ET1) and suppression of the nitric oxide (NO)/NO-synthase (NOS) pathway. This evidence concerns the gene NOS2 and endothelial dysfunction.